Scotts Miracle-Gro

SMG · NYSE

$55.86+$1.47 (+2.70%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $54.39

SMG analyst rating

BuyConsensus of 5 analysts over the last 12 months. 80% rate it a buy.

Strong buy0
Buy4
Hold1
Underperform0
Sell0

12-month price target · 6 analysts

Average $79.56 (+42.4% upside)

Low: $75.75
Now: $55.86
High: $86.10

Upgrades and downgrades

The latest rating actions, newest first

SMG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Oct 15, 2026	Upgrade	Neutral → Buy	$78.00 → $70.00	62%
Wells Fargo	Oct 5, 2026	Maintains	Overweight	$77.00 → $60.00	57%
Stifel	Sep 29, 2026	Maintains	Buy	$76.00 → $75.00	26%
Stifel	Aug 3, 2026	Maintains	Buy	$75.00 → $76.00	26%
UBS	Jul 30, 2026	Maintains	Neutral	$70.00 → $78.00	62%
Wells Fargo	Jul 30, 2026	Maintains	Overweight	$74.00 → $77.00	57%
UBS	Jul 16, 2026	Maintains	Neutral	$63.00 → $70.00	62%
Wells Fargo	Jul 8, 2026	Maintains	Overweight	$72.00 → $74.00	57%
Stifel	Jun 8, 2026	Maintains	Buy	$76.00 → $75.00	26%
Wells Fargo	Apr 8, 2026	Maintains	Overweight	$75.00 → $72.00	57%

The case for and against

Updated Jan 19, 2026

Bull case

Scotts Miracle-Gro has shown a substantial boost in consumer revenue, supported by a significant 50% benefit from favorable shipment timing, which highlights the strength of its US consumer segment. The company is expected to strategically invest in this advantaged platform, aiming to enhance operational efficiency and leverage in the consumer business. Additionally, revenue projections for fiscal years 2025 to 2027 have been revised upwards, largely due to improved gross margin performance, indicating a positive financial trajectory.

Bear case

The financial analysis indicates a negative outlook for Scotts Miracle-Gro, with projected revenue growth for the US consumer segment anticipated to decline by 1% for FY25, accompanied by a marginal decrease in EBITDA to $575 million. The company’s estimates remain below consensus, impacted by unfavorable below-the-line items and the normalization of share dilution, which presents an additional headwind for fiscal year 2025. Furthermore, the company faces multiple risks, including commodity volatility, broad market weakness, excess leverage, and the effects of unpredictable weather patterns, further compounding concerns regarding its financial stability and growth potential.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.